Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility

References

• Dhopeshwarkar A, Mackie K. CB2 cannabinoid receptors as a therapeutic target-what does the future hold? Mol Pharmacol 2014;86:430–7
   PubMed Web of Science ®Google Scholar
• Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 2006;105:1–25
   PubMed Web of Science ®Google Scholar
• Davis MP. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Expert Opin Investig Drugs 2014;23:1123–40
   PubMed Web of Science ®Google Scholar
• Attal N, Brasseur L, Guirimand D, et al. Are oral cannabinoids safe and effective in refractory neuropathic pain? Eur J Pain 2004;8:173–7
   PubMed Web of Science ®Google Scholar
• Dziadulewicz EK, Bevan SJ, Brain CT, et al. Naphthalen-1-yl-4-pentyloxynaphthalen-1-yl.methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J Med Chem 2007;50:3851–6
   PubMed Web of Science ®Google Scholar
• Gardin A, Kucher K, Kiese B, Appel-Dingemanse S. Cannabinoid receptor agonist 13, a novel cannabinoid agonist: first in human pharmacokinetics and safety. Drug Metab Dispos 2009;37:827–33
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Kathe N, Henriksen B, Chauhan H. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev Ind Pharm 2014;40:1565–75
   PubMed Web of Science ®Google Scholar
• Jones E, Ojewole E, Kalhapure R, Govender T. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. Drug Dev Ind Pharm 2014;40:669–79
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm 2013;39:508–19
   PubMed Web of Science ®Google Scholar
• Ruan Y, Yao L, Zhang B, et al. Nanoparticle-mediated delivery of Neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin. Drug Dev Ind Pharm 2012;38:123–8
   PubMed Web of Science ®Google Scholar
• Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 2010;27:1469–86
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Mueller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394–405
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62–76
   PubMed Web of Science ®Google Scholar
• Dodiya S, Chavhan S, Korde A, Sawant KK. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies. Drug Dev Ind Pharm 2013;39:733–43
   PubMed Web of Science ®Google Scholar
• Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm 2014;40:80–91
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Alka A. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 2009;17:249–56
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomed Nanotechnol 2009;5:184–91
   PubMed Web of Science ®Google Scholar
• Yuan H, Chen J, Du Y, et al. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloid Surface B 2007;58:157–64
   PubMed Web of Science ®Google Scholar
• Mueller RH, Runge S, Ravelli V, et al. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN (R)) versus drug nanocrystals. Int J Pharm 2006;317:82–9
   PubMed Web of Science ®Google Scholar
• Lopes R, Eleuterio CV, Goncalves LMD, et al. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci 2012;45:442–50
   PubMed Web of Science ®Google Scholar
• Mishra DK, Dhote V, Bhatnagar P, Mishra PK. Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research. Drug Deliv Transl Res 2012;2:238–53
   PubMed Web of Science ®Google Scholar
• Howard MD, Lu X, Jay M, Dziubla TD. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Dev Ind Pharm 2012;38:1270–9
   PubMed Web of Science ®Google Scholar
• Okonogi S, Riangjanapatee P. Potential technique for tiny crystalline detection in lycopene-loaded SLN and NLC development. Drug Dev Ind Pharm 2014;40:1378–85
   PubMed Web of Science ®Google Scholar
• Alvarez-Fuentes J, Martin-Banderas L, Munoz-Rubio I, et al. Development and validation of an RP-HPLC method for CB13 evaluation in several PLGA nanoparticle systems. Sci World J 2012;2012: 737526. doi: 10.1100/2012/737526
   Web of Science ®Google Scholar
• Cadete A, Figueirede L, Lopes R, et al. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Eur J Pharm Sci 2012;45:451–8
   PubMed Web of Science ®Google Scholar
• Durán-Lobato M, Martín-Banderas L, Gonçalves LM, et al. Comparative study of chitosan-and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids. J Nanopart Res 2015;17:1–17
   Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles - production, characterization and applications. Drug Deliv Rev 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, et al. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloid Surface B 2011;84:117–30
   PubMed Web of Science ®Google Scholar
• Abismail B, Canselier JP, Wilhelm AM, et al. Emulsification by ultrasound: drop size distribution and stability. Ultrason Sonochem 1999;6:75–83
   PubMed Web of Science ®Google Scholar
• Abismail B, Canselier JP, Wilhelm AM, et al. Emulsification processes: on-line study by multiple light scattering measurements. Ultrason Sonochem 2000;7:187–92
   PubMed Web of Science ®Google Scholar
• Chawla V, Saraf SA. Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Colloid Surface B 2012;92:293–8
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan R, Nakamura C, Mehnert W, et al. Glucocorticoid entrapment into lipid carriers – characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493–502
   PubMed Web of Science ®Google Scholar
• Urban-Morlan Z, Ganem-Rondero A, Maria Melgoza-Contreras L, et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. Int J Nanomed 2010;5:611–20
   PubMed Web of Science ®Google Scholar
• El-Kamel AH, Al-Fagih IM, Alsarra IA. Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization. J Microencapsul 2007;24:457–75
   PubMed Web of Science ®Google Scholar
• Chen S, Liu W, Wan J, et al. Preparation of coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm 2013;39:20–8
   PubMed Web of Science ®Google Scholar
• Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 2007;8:24
   PubMed Web of Science ®Google Scholar
• Jafari SM, Assadpoor E, He Y, Bhandari B. Re-coalescence of emulsion droplets during high-energy emulsification. Food Hydrocoll 2008;22:1191–202
   Web of Science ®Google Scholar
• Shah M, Pathak K. Development and statistical optimization of solid lipid nanoparticles of Simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech 2010;11:489–96
   PubMed Web of Science ®Google Scholar
• Anantachaisilp S, Smith SM, Treetong A, et al. Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution. Nanotechnology 2010;21:125102
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit J, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates - A review. J Control Release 2008;128:185–99
   PubMed Web of Science ®Google Scholar
• Hu H, Liu D, Zhao X, et al. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 2013;39:770–9
   PubMed Web of Science ®Google Scholar
• Kawadkar J, Pathak A, Kishore R, Chauhan MK. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 2013;39:569–78
   PubMed Web of Science ®Google Scholar
• Webb PA, Orr C. Analytical methods in fine particle technology. Norcorss, USA: Micromeritics Instrument Corp.; 1997
   Google Scholar
• Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 2005;61:77–86
   PubMed Web of Science ®Google Scholar
• Pandita D, Kumar S, Poonia N, Lather V. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res Int 2014;62:1165–74
   Web of Science ®Google Scholar
• Parveen R, Ahmad FJ, Iqbal Z, et al. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm 2014;40:1206–12
   PubMed Web of Science ®Google Scholar
• Li J, Guo X, Liu Z, et al. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev Ind Pharm 2014;40:980–7
   PubMed Web of Science ®Google Scholar
• Martin-Banderas L, Alvarez-Fuentes J, Duran-Lobato M, et al. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomed 2012;7:5793–806
   PubMed Web of Science ®Google Scholar
• Ezzati Nazhad Dolatabadi J, Hamishehkar H, Eskandani M, Valizadeh H. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloid Surface B 2014;117:21–8
   PubMed Web of Science ®Google Scholar